Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001190725-18-000017
Filing Date
2018-03-29
Accepted
2018-03-29 17:11:57
Documents
1
Period of Report
2018-03-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3970
  Complete submission text file 0001190725-18-000017.txt   5470
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2200 POWELL STREET, SUITE 310 EMERYVILLE CA 94608
Business Address
DATTA DEEPSHIKHA (Reporting) CIK: 0001731721 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14710 | Film No.: 18723872